Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2025-12-24 @ 4:45 PM
NCT ID:
NCT05077150
Eligibility Criteria:
Inclusion Criteria PCP cases:
* Allogeneic HSCT within the previous 24 months
* New case (first onset) of PcP documented in a BAL fluid, whatever the positive diagnostic test (cytology or IF or PCR) and whatever the presentation and treatment
* Any age
* Pre or post-transplant signed informed consent to enter the data in the EBMT registry
Exclusion Criteria PCP cases:
* Autologous HSCT
* Allogeneic HSCT recipient transplanted more than 24 months at time of the onset of PcP
* Second episode of PcP since allogeneic HSCT (patients who had experienced PcP before the allogeneic HSCT are not excluded).
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT05077150
Study Brief:
Protocol Section:
NCT05077150